When Hims & Hers Health (HIMS) introduced a sought-after alternative to Wegovy, the move reignited interest in an industry that had been struggling to gain momentum. The success of the obesity drug has drawn attention to telehealth, an industry that is now attracting massive growth projections and fueling sharp gains in some stocks through 2025.

 

Telehealth is being viewed as a potential game-changer in the health care system. By using technology such as smartphones, tablets, and computers, patients are able to consult with physicians, undergo monitoring, and even complete certain diagnostic tests from their homes. The sector’s expansion comes at a critical moment, with shortages of medical professionals becoming more acute after the pandemic, leaving many communities with minimal access to in-person services.

 

Industry estimates value the telehealth market at around $186 billion, with forecasts suggesting it could grow nearly four times in the next seven years. This surge is linked in part to the popularity of new weight-loss medications and cheaper alternatives, which are pushing more patients to turn to digital health platforms for care.

 

Justin Schreiber, chief executive of LifeMD (LFMD), highlighted that nearly half of the U.S. population lacks a consistent relationship with a primary care doctor. “People are increasingly relying on the internet. With the shortage of providers nationwide, the only viable solution lies in technology-enabled health care delivery systems,” he said.

 

LifeMD positions itself as a membership-style service, offering patients access to both primary and specialist doctors, as well as urgent care providers. Schreiber likened the company’s model to a “Costco or Amazon Prime” for telehealth, aiming to create affordable, accessible care for a wide range of patients.